ArticleJournal of nephrology2017
Economic burden of chronic kidney disease in Korea using national sample cohort.
Article in Journal of nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed.
- Economics of drug-coated balloons for arteriovenous fistula stenosis in Japan and Korea based on the IN.PACT AV access trial.Nephrology (Carlton, Vic.) · 2022Trial
- From data to policy: addressing the economic burden of biopsy-proven kidney diseases.Kidney research and clinical practice · 2026Article
- Combined application of deep learning and conventional computer vision for kidney ultrasound image classification in chronic kidney disease: preliminary study.Ultrasonography (Seoul, Korea) · 2025Article
- Epidemiology and economic burden of end-stage kidney disease by age, gender, and province among Iranian Hajj pilgrims in 2012-22: a retrospective study of 469,581 participants.BMC nephrology · 2025Article
- Economic burden of end stage renal disease: a case study in southern Iran.Health economics review · 2025Article
- Hospitalization among adults with chronic kidney disease: results from the KoreaN cohort study for Outcomes in patients With Chronic Kidney Disease (KNOW-CKD) study.Kidney research and clinical practice · 2025Article
- Economic burden of inpatient hospitalizations for pediatric chronic kidney disease in the US.Pediatric nephrology (Berlin, Germany) · 2025Article
- The impact of low dietary inflammatory index diet on clinical parameters in patients with chronic kidney disease: a retrospective comparative study.BMC nephrology · 2025Article
- Present and Future Applications of Artificial Intelligence in Kidney Transplantation.Journal of clinical medicine · 2024Review
- The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review.Cost effectiveness and resource allocation : C/E · 2024Article
- Real-world evidence of constipation and laxative use in the Korean population with chronic kidney disease from a common data model.Scientific reports · 2024Observational
- Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future.Kidney research and clinical practice · 2024Article
- The association between skipping breakfast and chronic kidney disease.International urology and nephrology · 2023Article
- Shared Decision Making for Choosing renAl Replacement Therapy in Chronic Kidney Disease Patients (SDM-ART trial): study protocol for randomized clinical trial.Kidney research and clinical practice · 2023Article
- Healthcare costs after kidney transplantation compared to dialysis based on propensity score methods and real world longitudinal register data from Sweden.Scientific reports · 2023Article
- Quality of Life and Kidney Function in Older Adults: Prospective Data of the SCOPE Study.Journal of clinical medicine · 2023Article
- Regional Differences in Medical Costs of Chronic Kidney Disease in the South Korean Population: Marginalized Two-Part Model.JMIR public health and surveillance · 2023Article
- The direct cost of dialysis supported by families for patients with chronic renal failure in Ouagadougou (Burkina Faso).BMC nephrology · 2022Article
- Evaluating a shared decision-making intervention regarding dialysis modality: development and validation of self-assessment items for patients with chronic kidney disease.Kidney research and clinical practice · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundDetermining the cost of a disease is one of the approaches to estimate the burden of the disease. This study was aimed to estimate the socioeconomic burden of chronic kidney disease (CKD) by CKD stages and treatment strategies in Korea.
methodsThis was a population-based study designed to estimate the cost of CKD according to CKD stages and treatment strategies from a societal perspective in Korea using multiple data sources. Costs of CKD stages III, IV, and V, hemodialysis (HD), and peritoneal dialysis (PD) were estimated with a prevalence-based method. Costs of kidney transplantation (KT) and post kidney transplantation were estimated using an incidence-based method. Costs consisted of direct medical cost, productivity loss cost due to hospitalization and outpatient visit, caregiver cost, and transportation cost.
resultsDirect medical cost per year per patient with CKD stages III, IV, and V were 1205, 1963, and 8035 Euros, respectively. Direct medical cost per year per patient receiving HD and PD was 34,554 and 25,806 Euros, respectively. Medical cost per year per KT patient was 68,798 Euros. Direct medical cost which accounted for 70% of the total cost of CKD IV and 87% of the total cost of post KT. Cost associated with productivity loss was approximately 8-20%.
conclusionsOur findings could be useful for evaluating cost-effectiveness of various CKD interventions including the screening strategy. This study also emphasizes a remarkable increase in the socioeconomic burden associated with the progression of CKD in patients.
Indexed as
Identifiers
28303461What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.